HRA006115
Title:
FUSCC PCMC mutation data
Release date:
2025-11-27
Description:
Remarkable advances in next-generation sequencing technology enable the wide usage of sequencing as a clinical tool. Here, we conducted a large-scale prospective clinical sequencing program using the Fudan-BC panel, and comprehensively analyzed the clinical and genomic characteristics for Chinese breast cancer. A total of 4,079 consecutive Chinese patients who were treated at the Department of Breast Surgery at Fudan University Shanghai Cancer Center (FUSCC) were enrolled in this cohort from April 1, 2018, to June 1, 2021.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
breast cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC of breast cancer
Contact person:
Shao Zhi-Ming
Email:
zhimin_shao@yeah.net
Description:
DAC of breast cancer
Individuals & samples
Submitter:   Shao Zhi-Ming / zhimin_shao@yeah.net
Organization:   Fudan University Shanghai Cancer Center
Submission date:   2023-11-27
Requests:   -